Utah Medical Prod (UTMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 6,014 | 6,258 | 7,205 | 7,905 | 8,168 |
| Depreciation Amortization | 607 | 589 | 591 | 597 | 634 |
| Income taxes - deferred | 0 | 230 | -46 | 93 | 118 |
| Accounts receivable | 110 | 290 | 365 | -117 | -37 |
| Accounts payable and accrued liabilities | 52 | -73 | 25 | -207 | 74 |
| Other Working Capital | 484 | 256 | 27 | -197 | 690 |
| Other Operating Activity | -110 | -324 | -405 | -600 | -1,244 |
| Operating Cash Flow | $7,157 | $7,226 | $7,762 | $7,474 | $8,403 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,532 | -466 | -274 | -307 | -334 |
| Purchase Of Investment | -1,600 | -3,800 | -2,650 | -2,000 | -6,600 |
| Sale Of Investment | 5,839 | 1,116 | 7,792 | 2,023 | 4,306 |
| Purchase Sale Intangibles | -2 | -8 | -13 | -53 | N/A |
| Other Investing Activity | -2 | -8 | -12 | -53 | 0 |
| Investing Cash Flow | $2,705 | $-3,158 | $4,856 | $-337 | $-2,628 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -413 | -463 | -1,917 | -1,239 | -1,057 |
| Common Stock Issued | 425 | 132 | 224 | 180 | 627 |
| Common Stock Repurchased | -439 | -116 | -7,792 | -2,023 | -4,794 |
| Dividend Paid | -6,030 | -3,337 | -4,329 | -3,423 | -2,902 |
| Other Financing Activity | 38 | 14 | 42 | 60 | 2,450 |
| Financing Cash Flow | $-6,419 | $-3,770 | $-13,772 | $-6,445 | $-5,676 |
| Exchange Rate Effect | -35 | 15 | 1 | -52 | -191 |
| Beginning Cash Position | 410 | 97 | 1,251 | 610 | 703 |
| End Cash Position | 3,818 | 410 | 97 | 1,251 | 610 |
| Net Cash Flow | $3,408 | $313 | $-1,153 | $640 | $-92 |
| Free Cash Flow | |||||
| Operating Cash Flow | 7,157 | 7,226 | 7,762 | 7,474 | 8,403 |
| Capital Expenditure | -1,532 | -466 | -274 | -307 | -334 |
| Free Cash Flow | 5,625 | 6,760 | 7,488 | 7,167 | 8,069 |